Topic: How To Invest

Stock Pickers Digest Hotline – Friday, September 6, 2019

Article Excerpt

RESMED INC., $140.30, symbol RMD on New York, makes and distributes CPAP (nasal continuous positive airway pressure) medical devices. They are used to treat patients with sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Sleep apnea can put immense strain on the body. An immediate short-term effect is sleep deprivation, but over time that can result in low energy, irritability, memory loss, lack of concentration and depression. In the three months ended June 30, 2019, revenue rose 13.1%, to $705.0 million from $623.6 million a year earlier. That’s mainly due to the company’s launch of new masks and upgrades to its products. Earnings in the quarter, excluding unusual items, rose 1.0%, to $137.6 million, or $0.95 a share, from $136.3 million, or $0.95. ResMed holds $147.1 million, or $1.03 a share in cash. It had long-term debt of $1.3 billion, or a low 6.4% of its market cap. The company’s shares yield 1.1%. The stock continues to hit all-time highs, and trades…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.